Table 2.
Characteristics of validation cohort
| Morbidity(n = 12) | Control(n = 21) | *p value | |
|---|---|---|---|
| Gender male n% | 10(83%) | 14(67.7%) | 0.0096 |
| pH | 7.16(0.19) | 7.156(0.19) | 0.87855251 |
| Scr (mg/dL) | 1.3276(0.2802) | 1.4266(0.5148) | 0.47718778 |
| BUN (mg/dL) | 12.50(5.27) | 13.39(6.29) | 0.66546308 |
| K+ (mEq/L) | 5.54(1.30) | 5.53(1.36) | 0.97629452 |
| Na+ (mEq/L) | 137.23(7.63) | 139.25(7.29) | 0.46464174 |
| WBC (K/uL) | 14.45(4.89) | 15.29(6.52) | 0.67758494 |
| Hb (g/dL) | 10.59(1.98) | 9.74(1.99) | 0.24255486 |
| PLT (K/uL) | 109.81(37.45) | 103.02(39.89) | 0.62799096 |
| Lactate (mmol/L) | 3.54(1.43) | 2.28(2.02) | 0.04430989 |
| CRP (mg/dL) | 67.27(17.12) | 68.3(14.82) | 0.86302044 |
| IL6 (pg/mL) | 785.49(154.24) | 728.52(146.97) | 0.30742201 |
| TNF (ng/L) | 53.31(13.28) | 48.90(12.05) | 0.35103748 |
| CD4 (#/uL) | 369.0(85.7) | 367.5(95.0) | 0.96201768 |
| CD8 (#/uL) | 403.8(105.4) | 39.58(9.75) | 0.83142445 |
| SOFA | 6.38(1.24) | 6.66(0.98) | 0.50066978 |
Data were presented as mean(sd). *Two-tailed t-test was used for numerical data; chi-square test was used for gender. Scr: serum creatinine; BUN: blood urea nitrogen; K+: potassium; Na+: Sodium; WBC: white blood cell; Hb: hemoglobin; CRP: C-reactive protein; IL6: interleukin-6; TNF: tumor necrotic factor; PLT: platelet counts